What is new? • Few small population/rare disease trials are using Bayesian methods and those that don't are ending up under sized and underpowered. • Researchers in rare disease and small population trials should be striving to use Bayesian methods where possible or follow recommendations suggested by Parmar et al. (2016) Abstract Objective : Frequentist trials in Rare disease/small population trials often require unfeasibly large sample size to detect minimum clinically important differences.
Alexina J. Mason
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Alexina J.
Contact Alexina J., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack